MECP2 and Rett syndrome: Overall, aside from the major genetic contribution (~80%) of MECP2 to Rett Syndrome, patients with and without the mutation have a reduction in the abundance and perhaps the maturation of inhibitory neurotransmission, independent and dependent of MECP2.